Take a deep breath
Yes we know that Monday isn’t the normal day to release another version of our Wacky World of Diabetes podcast but this isn’t exactly a normal podcast either as we are delighted to welcome Michael Castagna CEO of MannKind to our list of distinguished guest.
As longtime subscribers know we’ve been following MannKind since day one when the late Al Mann founded the company. To say that MannKind and their lead product Afrezza has had it’s share of ups and downs is a vast understatement. Afrezza may never be the blockbuster drug that many anticipated in an ironic twist it is the ultra rapid acting insulin that so many want. Even more ironic had Afrezza been a conventional injectable insulin rather than inhaled it likely would have been a huge seller.
Since taking over the company Michael has faced several challenges to keep MannKind afloat. He’s also begun transforming MannKind from a diabetes company to a drug delivery company. While Afrezza will always be near and dear to the company it is no longer the only offering. So take a listen and enjoy.
